Ware RE - Search Results

1

Shared decision making for hydroxyurea treatment initiation in children with sickle cell anemia.

Crosby LE, Shook LM, Ware RE, Brinkman WB. Crosby LE, et al. Among authors: ware re. Pediatr Blood Cancer. 2015 Feb;62(2):184-185. doi: 10.1002/pbc.25124. Epub 2014 Oct 12. Pediatr Blood Cancer. 2015. PMID: 25308571 Free PMC article.

2

UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia.

Heeney MM, Howard TA, Zimmerman SA, Ware RE. Heeney MM, et al. Among authors: ware re. J Lab Clin Med. 2003 Apr;141(4):279-82. doi: 10.1067/mlc.2003.28. J Lab Clin Med. 2003. PMID: 12677174 Clinical Trial.

3

Subclinical parvovirus B19 infection in children with sickle cell anemia.

Zimmerman SA, Davis JS, Schultz WH, Ware RE. Zimmerman SA, et al. Among authors: ware re. J Pediatr Hematol Oncol. 2003 May;25(5):387-9. doi: 10.1097/00043426-200305000-00007. J Pediatr Hematol Oncol. 2003. PMID: 12759625

4

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease.

Zimmerman SA, Schultz WH, Davis JS, Pickens CV, Mortier NA, Howard TA, Ware RE. Zimmerman SA, et al. Among authors: ware re. Blood. 2004 Mar 15;103(6):2039-45. doi: 10.1182/blood-2003-07-2475. Epub 2003 Nov 20. Blood. 2004. PMID: 14630791 Free article. Clinical Trial.

5

Chemical and functional analysis of hydroxyurea oral solutions.

Heeney MM, Whorton MR, Howard TA, Johnson CA, Ware RE. Heeney MM, et al. Among authors: ware re. J Pediatr Hematol Oncol. 2004 Mar;26(3):179-84. doi: 10.1097/00043426-200403000-00007. J Pediatr Hematol Oncol. 2004. PMID: 15125610

6

Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.

Ware RE, Zimmerman SA, Sylvestre PB, Mortier NA, Davis JS, Treem WR, Schultz WH. Ware RE, et al. J Pediatr. 2004 Sep;145(3):346-52. doi: 10.1016/j.jpeds.2004.04.058. J Pediatr. 2004. PMID: 15343189

7

Enalapril and hydroxyurea therapy for children with sickle nephropathy.

Fitzhugh CD, Wigfall DR, Ware RE. Fitzhugh CD, et al. Among authors: ware re. Pediatr Blood Cancer. 2005 Dec;45(7):982-5. doi: 10.1002/pbc.20296. Pediatr Blood Cancer. 2005. PMID: 15704213

8

Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study.

Hankins JS, Ware RE, Rogers ZR, Wynn LW, Lane PA, Scott JP, Wang WC. Hankins JS, et al. Among authors: ware re. Blood. 2005 Oct 1;106(7):2269-75. doi: 10.1182/Blood-2004-12-4973. Blood. 2005. PMID: 16172253 Free PMC article. Clinical Trial.

9

Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia.

Zimmerman SA, Schultz WH, Burgett S, Mortier NA, Ware RE. Zimmerman SA, et al. Among authors: ware re. Blood. 2007 Aug 1;110(3):1043-7. doi: 10.1182/blood-2006-11-057893. Epub 2007 Apr 11. Blood. 2007. PMID: 17429008 Free article. Clinical Trial.

10

Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea.

Hankins JS, Helton KJ, McCarville MB, Li CS, Wang WC, Ware RE. Hankins JS, et al. Among authors: ware re. Pediatr Blood Cancer. 2008 Feb;50(2):293-7. doi: 10.1002/pbc.21271. Pediatr Blood Cancer. 2008. PMID: 17554794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters